The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma

被引：0
|
作者：
Liang Peng
Jin-Qi Liu
Cheng Xu
Xiao-Dan Huang
Ling-Long Tang
Yu-Pei Chen
Ying Sun
Jun Ma
机构：
[1] Sun Yat-sen University Cancer Center,Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
来源：
Radiation Oncology | / 14卷
关键词：
Nasopharyngeal carcinoma; Interval; Induction chemotherapy; Radiotherapy; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma
    Peng, Liang
    Liu, Jin-Qi
    Xu, Cheng
    Huang, Xiao-Dan
    Tang, Ling-Long
    Chen, Yu-Pei
    Sun, Ying
    Ma, Jun
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [2] The impact of the interval between the induction of chemotherapy and radiotherapy on the survival of patients with nasopharyngeal carcinoma
    Yang, Shiping
    Fu, Xiaoling
    Huang, Guang
    Chen, Junni
    Luo, Shishi
    Wang, Zhenping
    Kong, Fanzhong
    Wu, Gang
    Lin, Shaomin
    Wang, Fen
    Chen, Longhua
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2313 - 2320
  • [3] Effect of waiting time for radiotherapy after last induction chemotherapy on prognosis of locally advanced nasopharyngeal carcinoma
    Zhu, Kui-Xuan
    Ding, Ting
    Yimin, E.
    Yang, Hong-Wei
    Wu, Rui-Ping
    Liu, Run-Jia
    Zhou, Ling-Li
    Fu, Wen-Jie
    Jiang, Mei-Ping
    Wang, Xiao-Li
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (05): : 1189 - 1200
  • [4] Association between multidrug resistance-associated protein 1 and poor prognosis in patients with nasopharyngeal carcinoma treated with radiotherapy and concurrent chemotherapy
    Larkharoensub, Noppadol
    Leopairat, Juvady
    Sirachainan, Ekaphop
    Narkwong, Ladawan
    Bhongmakapat, Thongchai
    Rasmeepaisarn, Kawin
    Janvitisri, Tavan
    HUMAN PATHOLOGY, 2008, 39 (06) : 837 - 845
  • [5] Reduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinoma
    Liu, Na
    Cui, Rui-Xue
    He, Qing-Mei
    Huang, Bi-Jun
    Sun, Ying
    Xie, Dan
    Zeng, Jing
    Wang, Hui-Yun
    Ma, Jun
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [6] High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma
    Xu, Ya-Fei
    Ren, Xian-Yue
    Li, Ying-Qin
    He, Qing-Mei
    Tang, Xin-Ran
    Sun, Ying
    Shao, Jian-Yong
    Jia, Wei-Hua
    Kang, Tie-Bang
    Zeng, Mu-Sheng
    Liu, Na
    Ma, Jun
    BMC CANCER, 2015, 15
  • [7] Construction and validation of a biochemical signature to predict the prognosis and the benefit of induction chemotherapy in patients with nasopharyngeal carcinoma
    Sun, Xue-Song
    Liu, Sai-Lan
    Xie, Si-Yi
    Sun, Rui
    Luo, Dong-Hua
    Chen, Qiu-Yan
    Mai, Hai-Qiang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (04): : 1635 - +
  • [8] Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
    Li, Ying
    Bi, Jianping
    Pi, Guoliang
    He, Hanping
    Li, Yanping
    Zheng, Dandan
    Wei, Zecheng
    Han, Guang
    CANCER MEDICINE, 2023, 12 (08): : 9449 - 9457
  • [9] Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma - Results of a matched cohort study
    Geara, FB
    Glisson, BS
    Sanguineti, G
    Tucker, SL
    Garden, AS
    Ang, KK
    Lippman, SM
    Clayman, GL
    Goepfert, H
    Peters, LJ
    Hong, WK
    CANCER, 1997, 79 (07) : 1279 - 1286
  • [10] High VCAM-1 Predicts Poor Prognosis and is Associated with Chemotherapy Resistance in Nasopharyngeal Carcinoma
    Huang, Yu
    Miao, Hongbin
    Xia, Chenxi
    Feng, Huajun
    Xu, Shengen
    Liang, Zhuoping
    Wang, Yuanyuan
    Zhao, Chong
    Qin, Gang
    Ou, Xiaoyi
    Zhao, Feipeng
    ONCOTARGETS AND THERAPY, 2021, 14 : 1633 - 1641
12345